Abstract
miRNA-20b has been shown to be aberrantly expressed in several tumor types. However, the clinical significance of miRNA-20b in the prognosis of patients with hepatocellular carcinoma (HCC) is poorly understood, and the exact role of miRNA-20b in HCC remains unclear. The aim of the present study was to investigate the association of the expression of miR-20b with clinicopathological characteristics and overall survival of HCC patients analyzed by Kaplan-Meier analysis and Cox proportional hazards regression models. Meanwhile, the HIF-1α and VEGF targets of miR-20b have been confirmed. We found not only miR-20b regulation of HIF-1α and VEGF in normal but also regulation of miR-20b in hypoxia. This mechanism would help the tumor cells adapt to the different environments thus promoting the tumor invasion and development. The whole study suggests that miR-20b, HIF-1α, and VEGF serve as a potential therapeutic agent for hepatocellular carcinoma.
Cite
CITATION STYLE
Xue, T. M., Tao, L. D., Zhang, M., Zhang, J., Liu, X., Chen, G. F., … Zhang, P. J. (2015). Clinicopathological significance of MicroRNA-20b expression in hepatocellular carcinoma and regulation of HIF-1 α and VEGF effect on cell biological behaviour. Disease Markers, 2015. https://doi.org/10.1155/2015/325176
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.